Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
thiamine + pyridoxine + cyanocobalamin (Shanghai Universal Biotech)
- Development stage
- Unknown
- Lead developer
- Universal Corporation
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Neuroba is a combination pharmaceutical product containing the neurotropic B vitamins thiamine (B1), pyridoxine (B6), and cyanocobalamin (B12). Developed and manufactured by Universal Corporation (Kenya), it is approved for the treatment of various nervous system conditions, including peripheral neuropathy, neuritis, and neuralgia resulting from vitamin B deficiencies. The components work synergistically to support nerve health: thiamine acts as a cofactor in energy metabolism and nerve impulse transmission; pyridoxine is essential for the synthesis of neurotransmitters such as serotonin and GABA; and cyanocobalamin is critical for the maintenance of the myelin sheath and DNA synthesis. By addressing vitamin B deficiencies, Neuroba helps alleviate symptoms of nerve damage and promotes neurological health.
- Brand names
- Neuroba
- Other names
- Vitamin B1 + Vitamin B6 + Vitamin B12Neurotropic B vitamins
02
Targets
TKT (Transketolase)OGDH (Dihydrolipoamide S-succinyltransferase)MMUT (Methylmalonyl-coenzyme A mutase)PDH (Pyruvate dehydrogenase complex)MTR (Methionine synthase)
Beyond the preview
Go deeper on thiamine + pyridoxine + cyanocobalamin (Shanghai Universal Biotech).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on thiamine + pyridoxine + cyanocobalamin (Shanghai Universal Biotech).